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Summary A human malignant pleural mesothelioma was xenografted serially in athymic nude Rowett rats
for 27 passages during 33 months. After the two initial passages (P), the take rate during P3-9 was 100%
(192/192). The tumour grew progressively during P3-9 in 99% (190/192) and regressed totally in 1% (2/192).
The take rate for the tumour xenografted to athymic BALB/c mice was also 100% (17/17) and no regressions
were observed. During serial passaging in nude rats, the tumour-volume doubling time (TD) decreased from 6
days in P2 to 3 days in P8-9 (P<0.001) and then remained around 3 days during P10-25. A TD of 11 days
in P1 (man-mouse) for tumours grown in mice decreased during 10 passages in rats to 4 days (P<0.005)
when the tumour was transplanted to mice in P11. Light microscopic morphology of the tumour was retained
in rats and mice. We believe that our experimental tumour model using the nude rat as a carrier of the
xenograft will be useful for studies of human mesothelioma.
Malignant human pleural mesothelioma (MHPM) is a rare
tumour with a poor prognosis. The evaluation of chemo-
and radiotherapy is difficult in MHPM owing to difficulties
in measuring the tumour volume, lack of a generally
accepted staging system (Dimitrov et al., 1983) and different
prognoses in the three main histologic subtypes of this
tumour (Elmes & Simpson, 1976).
Growth of human tumour xenografts in athymic nude
mice or artificially immunosuppressed mice is regarded as
the best currently available experimental model for studying
the response of human tumours to drugs (Pihl, 1986). Most
human malignant tumours, including pleural mesotheliomas
(Chahinian et al., 1980; Linden et al., 1982), have been
xenografted to athymic mice.
Festing et al. (1978) described an athymic nude rat with
an immunodeficiency state comparable to that of the athy-
mic mouse, suggested to be more robust for certain experi-
mental situations, e.g., for experiments requiring surgical
manipulations and frequent blood sampling.
Experience with the athymic rat is sparse compared to that
with the athymic mouse, but many human malignant
tumours, including one human malignant pleural mesothe-
lioma (Linden et al., 1982), have been successfully xeno-
grafted to rats.
In the present study we transplanted another MHPM to
both athymic rats and mice and studied the long-term
growth pattern of this tumour line in nude rats. We also




A 66-year old man was found to have an epithelial pleural
mesothelioma at thoracoscopic biopsy of the parietal pleura.
The tumour was treated with irradiation to a total dose of
40 Gy. About 2 weeks after the completion of the radio-
therapy against the diseased hemithorax, an implantation
metastasis was noted in the former needle tracks. This
tumour nodule was excised and used for establishing this
(AKG) tumour cell line. The patient was treated further with
3 courses of combined chemotherapy consisting of doxo-
rubicin and cyclophosphamide, but in spite of this treatment
the tumour progressed and he died. At autopsy the diagnosis
was confirmed and bilateral calcified pleural plaques were
noted, indicating asbestos exposure.
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Tumour morphology
Tissue from the primary tumour in the pleural cavity was
examined and compared with tumour tissue from xenografts
grown in rats in passage 1, 19 and 26 and in mice in passage
I and 11. Formalin-fixed and paraffin-embedded blocks were
used. The sections were stained with haematoxylin-eosin, van
Gieson, alcian blue (pH 2.5) before and after hyaluronidase
digestion and PAS (periodic acid-Schiff) before and after
diastase digestion (D-PAS).
Immunohistochemistry Formalin-fixed and paraffin embed-
ded blocks were used with the peroxidase-antiperoxidase
(PAP) method using rabbit-antibodies directed against two
different cytokeratins, CAM 5.2 (B&D) and AE1/AE3
(Hybritech), epithelial membrane antigen (EMA, Dako),
carcinoembryonic antigen (CEA, Dako), vimentin (Dako)
and desmin (Dako). Sections with known antigen content
were used as positive controls. The staining was scored as
absent, weak, moderate or strong.
Animals
Rats A breeding colony of congenitally athymic nude
Rowett rats was established in 1981 with heterozygous rnu/+
rats procured from Moellegaard Breeding Centre Ltd, Lille
Skensved, Denmark. Heterozygous rnu/+ female rats were
mated with homozygous rnu/rnu males. Food, bedding and
cages were sterilized. Tap water acidified to a pH 2 was used
as water supply. The animals were used for transplantation
at an age of 4-8 weeks.
Mice A breeding nucleus of athymic BALB/c mice was
obtained in 1977 from Gl. Bomholtsgard Laboratory
Animals Breeding and Research Centre, Ry, Denmark and
maintained under the same conditions as the athymic rats.
The nude mice were used for transplantation experiments
from the age of 4-8 weeks.
Transplantations
The tumour specimen was processed into a coarse cell
suspension and inoculated s.c. under general ether
anaesthesia.
In the first passage (man-animal) 1 g tumour suspension
was injected into each animal, rats as well as mice. In a
second passage in rats 1.6g of tumour suspension were
injected into each animal. From the third transplantation
generation all further inoculations in rats, as well as in mice,
were made with 0.5 g of tumour suspension dissolved in
0.5ml sterile isotonic saline per animal. The size of the
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tumours was measured with a slide caliper once a week,
while the rats were under general ether anaesthesia. Three
perpendicular diameters, length, width and height were mea-
sured. The absolute tumour volume was estimated as the
volume of the ellipsoid. Hence, tumour volume was calcu-
lated as length x width x height x 0.5. To calculate the time
needed for an individual tumour to reach a preselected
tumour volume in cm3 and the tumour volume doubling
time (TD) in days in a certain tumour volume range, we
used the regression equation of each tumour's growth curve
in the appropriate tumour volume range. Calculation of
growth characteristics was made only in firm tumours show-
ing established growth assumed to be exponential.
Statistical analysis
Means were compared with Mann-Whitney U test and
proportions with Fisher's exact probability test. Spearman's
rank correlation test was used to analyze correlations.
P<0.01 was regarded as a significant difference. All P values
were calculated for two tails.
Results
Tumour morphology
The polygonal tumour cells grew in large sheets, usually with
moderate atypia. No papillary, tubular or glandular differen-
tiation was recorded. The morphology was consistent with a
malignant mesothelioma of epithelial type. The histological
pattern was retained in all xenograft generations in rats and
mice and no change in the grade of differentiation was
observed (Figure 1). Staining for neutral mucins with PAS-
diastase was negative, as was staining for acid mucins with
alcian blue-hyaluronidase (pH 2.5). Varying degrees of necro-
sis were seen in the primary tumour and in the xenografts in
rats and mice, but were unrelated to tumour generation or
tumour bearing species.
The immunoreactivity was recorded as strong or moderate
for cytokeratin and EMA and absent for CEA, vimentin and
desmin. The staining pattern was retained in the xenografts
in rats and mice.
Transplantation
The tumour was serially passaged in rats for a total of 27
generations over 33 months. In the first passage (P) (man-
animal) the tumour suspension was inoculated into mice and
rats (Figure 2). The serial propagation, however, was carried
out exclusively in rats. The take rate in rats was 93% (13/14)
in the 2 initial passages and 100% (192/192) in P3-9.
Likewise, in mice inoculated with the tumour (P1 and P11)
the take rate was 100% (17/17).
One percent (2/205) of the tumours growing in rats
regressed totally during P1-P9 and none in mice (0/17) (P1
and Pll). Thus, there was no statistically significant differ-
ence between rats and mice regarding rates of take and
regression. The tumour volume doubling time (TD) de-
creased during serial passage in rats from 6 days in P2 to 3
days in P8-9 (P<0.001) (Figure 3), but was then retained at
around 3 days during further passaging in rats (P10-25)
(P>0.05) (Figure 4). The time to reach a specified tumour
volume (TV) gives a total measure of the latency time for
tumour growth and the TD. The tumour reached a TV of
2cm3 after 36 days in P2 and this decreased to 15-16 days in
P8-9 (P<0.001) and to 11-12 days in PIO-12; after that no
further decrease was observed in passages P1O-P25.
To investigate if the increased growth rate in rats was
species-dependent, we transferred tumour tissue from rats in
PlO to mice (P11) (Figure 2) and compared the growth
parameters in mice with those in rats before and after one
tumour generation in mice. The TD in mice (P11), 4.2 days
at low TV (1-3cm3), was not significantly different
(P=0.03) from that in rats (3.6 days) in P10-12. However,
for larger tumours (TV>3cm3), the TD in rats (3.6 days),
compared to mice (9.3 days), was shorter (P<0.001). In
addition, the TVs were larger in rats than in mice
(P<0.0001), as illustrated in Figure 2. The TD for the
tumour grown in mice in P1 decreased from 11 days to 4
days in P11 (P<0.005) (Figure 2) and the time for the
tumour to grow to 4cm3 decreased from 79 days to 26 days
(P<0.005).
Discussion
The tumour was classified as an epithelial pleural meso-
thelioma according to established criteria (World Health
Organization, 1981). The immunohistochemical staining pat-
tern was characteristic for an epithelial mesothelioma with
absence of CEA and strong to moderate reactivity to
cytokeratins (Otis et al., 1987).
The xenografted tumour retained its histologic pattern and
its tumour antigens during 27 serial tumour generations in
rats and was not changed by transfer of the tumour to mice
for one generation. This preservation of the tumour morpho-
logy is in agreement with observations in nude mice that
human mesothelioma xenografts have retained their tumour
morphology during long-time serial passaging (Suzuki et al.,
1987). However, in experimentally induced animal meso-
theliomas, changes have been reported in the dominating
morphologic cell type of the tumour during serial passaging
in animals (Wagner et al., 1982).
In a comparison of the usefulness of nude rats versus nude
mice, it is important to evaluate the take rates of xeno-
grafted tumours. In our mesothelioma tumour line, the take
rate was roughly 100% in both nude rats and mice. How-
ever, no direct assessment of the lowest cell number required
for tumour take was made; this would have made a more
precise evaluation possible. The take rates for cells from
previously serially transplantable tumour lines or from prim-
ary explants have been reported to be equal in rats and mice
(Sawada et al., 1982; Matthews et al., 1982). However, in a
few studies the take rates have been observed to be lower in
nude rats (Maruo et al., 1982; Giovanella et al., 1984). In
addition, the take rate (Sawada et al., 1982; Maruo et al.,
1982; Drewinko et al., 1986) and growth rate (Maruo et al.,
1982) of xenografts in nude rats have been observed to
decrease with increasing age in the animal. This decrease of
take rate and growth rate is thought to be related to the
observed increase of host NK cell activity with ageing in the
nude rat (Lotzova et al., 1984).
The adaptive alterations of the internal properties of the
xenografted tumour are important, in addition to the inter-
action with the host. Our observation of an initial decrease
of the TD of the tumour grown in rats during the first 8-9
passages and a conservation of the growth rate during 18
further passages in rats is in agreement with reports of
human tumours serially transplanted in nude mice (Mattern
et al., 1980) and in immunodeficient mice (Houghton &
Taylor, 1978). After the initial decrease in TD of xenografted
tumours in nude mice, the growth rate has remained fairly
constant for long periods (Povlsen et al., 1975). However, in
a few tumours growth rate has been observed to increase in
later passages after an initial period of constant growth rate
(Fodstad et al., 1980). This increase in the growth rate of the
xenografted tumour may also be accompanied by an
increased sensitivity to chemotherapeutic agents (Fodstad et
al., 1983).
In an attempt to investigate if the increase in growth rate
during the initial passages in rats was a species-dependent
adaptation to the xenograft state in rats, we transferred the
tumour grown serially in rats for 10 generations to mice for
one passage and then retransplanted the tumour to rats
(Figure 2). The tumour grew with approximately the same
TD when grown in rats before and after one tumour
generation in mice. At low tumour volumes the TD was the616 C.-J. LINDEN & L. JOHANSSON
Figure 1 Photomicrograph of human pleural mesothelioma AKG of epithelial type. Polygonal cells growing in large sheets. (a)
Primary pleural tumour ( x 400); (b) Tumour xenografted in rat in passage 19 ( x 400); (c) Tumour xenograft grown in mouse in
passage 11 ( x 500). Note retained histologic appearance with similarity of cellular and nuclear features in (b) and (c) compared to
the original tumour (a). All sections were stained with H&E.
same in the 11th passage in mice as in the corresponding
passages in rats. However, the TD for tumours grown in
mice in 11M was significantly shorter than for tumours
grown in mice in the first passage (IM).
Our observations thus indicate that after the initial adap-
tation to the xenograft environment, the growth rate of the
tumour as a xenograft is not species-dependent in this
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Figure 2 Growth curves of mesothelioma AKG xenografted to
athymic rats (R) and athymic mice (M). In the first passage 1 g
tumour tissue from a chest-wall metastasis was transplanted to
each of 3 rats (0 IR) and 4 mice (O IM). From tumour tissue
grown in the 10th generation in rats (X IOR, n= 14), 0.5g
tumour tissue was transferred in the 11th passage to each of 12
rats ( IiR) and 13 mice (l 1iM). Tumour tissue grown in
mice in the 11th passage (1 M) was retransplanted to rats in
passage 12 (A 12BR, n =9). Concurrently, tumour tissue grown
in the 11th passage in rats was further transplanted to rats in the
12th passage (1l2AR, n= - 1). Circles and squares represent





















Figure 4 Evolution of tumour-volume doubling time (TD) for
mesothelioma AKG during serial passaging in athymic rats in
passages 10-25. Horizontal bars represent means and rs the
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Figure 3 Evolution of tumour-volume doubling time (TD) of
mesothelioma AKG during serial passaging in athymic rats
( R) for 9 tumour generations (lR-9R, n=205). 1M represents
the first passage in athymic mice (0, n=4). Horizontal bars
represent mean and rs the Spearman rank correlation coefficient.
a combined measure of TD and lag time for tumour growth,
decreased significantly in mice after 10 passages in rats
(Figure 2).
The reduced latency time for tumour growth in rats
(Figure 2) was not influenced by one tumour generation in
mice, supporting our hypothesis of a species independence of
the internal growth rate of the xenograft at low tumour
volumes. In contrast, the latency time for tumour growth in
our tumour seems to be significantly shorter in rats than in
mice (Figure 2).
This is in agreement with observations that some tumours
may grow significantly faster in rats than in mice
(Giovanella et al., 1984).
The growth rates of xenografted tumours generally
decrease with increasing volume of the tumour according to
the Gompertzian equation. The fact that the body weight of
the nude mouse is only about 1/10 of that of the rat results
in a much higher relative tumour weight in the mouse.
The calculated maximum tumour volumes for various
animal tumour systems indicate species and weight depen-
dence (Brunton & Wheldon, 1978). Theoretical calculations
of the maximal achievable tumour volumes of human
tumour xenografts in mice using the Gompertz equation
indicate maximal volumes to be in the range of those
actually found in mouse tumours (Rofstad et al., 1982).
We found that at tumour volumes above 3-5cm3 the
tumour growth rate in mice was significantly lower than in
rats. We suggest that the most probable explanation of the
lower tumour growth rate in mice at larger tumour volumes
is the lower body weight of the mice and not host factors of
an immunological nature.
Regressions of progressively growing human tumour xeno-
grafts have rarely been described in nude mice. In contrast,
early regression and regression after several months of
progressive growth are known in nude rats (Colston et al.,
1981; Stragand et al., 1982). We observed only 2 complete
tumour regressions in 205 tum6urs which grew in nude rats
and none in 17 nude mice. This indicates that the regression
rate in 4-8 week old nude rats roughly corresponds to that
in adult nude mice in this tumour line, although the number
of inoculated mice was far too few to permit detection of
minor differences.
The rate of tumour takes and regressions of growing
tumours in nude rats has been reported to be related to host
NK cell activity (Drewinko et al., 1986). Recently, it has
been observed that the NK cell activity in athymic rats is age
dependent, virtually absent in rats less than 3 weeks of age
and found to increase to adult levels at 7-10 weeks of age
(Lotzova et al., 1984).
This age dependency of the NK cell activity might explain
part of the reported variations in rates of take and
regression.
In conclusion, we have transplanted a human pleural
mesothelioma for 27 passages in athymic rats over a period
of 33 months. The tumour increased its growth rate during
the initial passages in rats and then retained its growth rate
for nearly 20 passages. This tumour also grew in nude mice
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but with the same growth rate at low tumour volumes. We
believe that the nude rat is a useful and robust carrier of our
mesothelioma xenograft and that the stable growth of this
tumour in nude rats will make the system useful for
experimental studies including drug testing.
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